Table 2.
Plasma proteins from global test comparing FTD, AD and controls
| Name | Associated with status | Statistica | Std. dev | p value |
|---|---|---|---|---|
| FN1.3 | AD | 8.72 | 0.406 | 2.26e−10 |
| Fibronectin | AD | 7.39 | 0.405 | 5.07e−09 |
| FN1.4 | AD | 7.18 | 0.406 | 2.04e−08 |
| VWF | AD | 7.01 | 0.407 | 3.65e−08 |
| ECM1 | AD | 4.23 | 0.398 | 1.94e−05 |
| ApoE | AD | 5.68 | 0.406 | 9.79e−07 |
Plasma proteins that attributed to a difference in expression profile between FTD, AD and controls after correction for multiple testing
All proteins were upregulated in AD compared to FTD and controls. Models were corrected for age and sex
FN 1.3 fibronectin fragment 3, FN 1.4 fibronectin fragment 4, VWF Von Willebrand factor, ECM1 extracellular matrix protein 1, ApoE apolipoprotein epsilon, AD Alzheimer’s disease
aRepresent the t statistics associated to the Global testing